Bing

SEARCH HISTORY

Monday sure didn’t do anything to disappoint those expectations for pharmaceuticals, adding upwards of $10 billion to the sector’s M&A tally. Roche contributed by far the least to total deal value, while anyone holding QCOR stock should be smiling.
Investor Place · ByDan Burrows · 4/7/2014
Investors in Questcor Pharmaceuticals Inc (NASD: QCOR) saw new options begin trading today, for the November 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the QCOR options chain for the new November 1st …
Forbes · 10/3/2013
ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial. Highlights from the ratings report include: QCOR's very impressive revenue growth greatly …
The Street · 10/19/2012
More from Bing News
Upcoming Aetna Policy Update has little downside, but lots of potential upside. Getting long QCOR now appears to make sense as the next major catalyst is Aetna's anticipated Policy Update on October 13th, which everyone expects will remain negative …
Reuters · 10/2/2012
Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >> QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report …
Yahoo Finance · 1/17/2014
My daily stock research process includes the running of several ... One company that keeps making regular appearances on my short-list of candidates is Questcor (QCOR). Questcor is a biopharmaceutical company focused on treating patients with …
Seeking Alpha · 2/2/2014
Questcor Pharmaceuticals, Inc. (QCOR) is going all crazy'n stuff today following kick-butt quarter. Robust sales for Acthar put to rest worries that reimbursement issues for newer uses of the drug might restrict sales, and the stock is up more than 30% as ...
istock Analyst · 7/31/2013
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) investors ... and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300) This is a FREE report from Insider Monkey. Credit Card is NOT required.
INSIDER MONKEY · 8/27/2013
as Citron has taken the extra steps necessary to uncover the "mystery" active ingredients in one of the most controversial drugs on the marketplace. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) has been a battleground stock for years. Bulls have stood ...
Value Walk · 2/28/2014
Questcor Pharmaceuticals, Inc. ( QCOR) was a big mover last session, as the company saw its shares shoot up nearly 19% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This …
NASDAQ · 4/8/2014